Information Provided By:
Fly News Breaks for January 8, 2018
Jan 8, 2018 | 09:20 EDT
Piper Jaffray analyst Matt O'Brien recommends investors purchase shares of Wright Medical following this morning's preliminary Q4 results. Wright reported preliminary Q4 revenue that beat consensus estimates, and importantly, 2017 sales came in at the high end of previously provided guidance range, O'Brien tells investors in a research note. The analyst sees a "solid set-up" for 2018 and keeps an Overweight rating on Wright Medical with a $32 price target.
News For WMGI From the Last 2 Days
There are no results for your query WMGI
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.